Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cellino Biotech
Biotech
Eric Topol boards Flagship as advisor—Chutes & Ladders
Eric Topol boards Flagship as advisor. Idorsia CEO hits the exit. Mestag adds $40 million, two new C-suiters.
Darren Incorvaia
,
Zoey Becker
,
Will Maddox
Mar 20, 2026 8:30am
Cardiff Oncology churns C-suite—Chutes & Ladders
Jan 30, 2026 8:30am
Expect further market correction in tariff-driven era: PitchBook
Apr 18, 2025 7:51am
Stanford economist is Trump's NIH pick—Chutes & Ladders
Dec 6, 2024 8:30am
FDA shores up executive team with 2 hires—Chutes & Ladders
Jul 1, 2022 9:30am